Because PTX binds to cell surface receptors present on malignant and benign cells, and acts more effectively upon HNSCC cells, there is a need to pay more attention to this natural product to further define the way of its optimal potential use which may extend our knowledge of the biology of head and neck cancer. The gene discussed is CD177; the disease is head and neck squamous cell carcinoma.